Crewe Advisors LLC
Source: SEC Form 13F · as of Mar 2026Crewe Advisors LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $482K in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$482K
BioSniper AIPage evidence connected
Prepared research question
What matters most for Adaptive Biotechnologies Corp (ADPT)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ADPTAdaptive Biotechnologies Corp | 11,543 | $160K |
| GILDGILEAD SCIENCES, INC. | 781 | $109K |
| DFTXDefinium Therapeutics Inc. | 1,999 | $38K |
| MRNAModerna, Inc. | 726 | $37K |
| LGNDLigand Pharmaceuticals Incorporated | 181 | $36K |
| ASBPAspire Biopharma Holdings Inc. | 20,335 | $21K |
| ATAIAtai Beckley N.V. | 5,540 | $20K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 264 | $15K |
| GERNGERON CORP | 7,950 | $12K |
| CMPSCOMPASS Pathways plc | 1,945 | $11K |
| TGTXTG THERAPEUTICS, INC. | 237 | $8K |
| REGNREGENERON PHARMACEUTICALS, INC. | 8 | $6K |
| VCELVericel Corp | 168 | $5K |
| IONSIONIS PHARMACEUTICALS INC | 48 | $4K |
| SNYSanofi | 34 | $2K |
| OGNOrganon & Co. | 12 | $72 |
| SGMOQSANGAMO THERAPEUTICS, INC | 100 | $25 |
| OPKOPKO HEALTH, INC. | 1 | $2 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.